Target intelligence / Profile preview

Cytochrome P450 3A2 (CYP3A2)

Target
CYP3A2
Molecular classification
Enzyme, Oxidoreductase, Cytochrome P450 family
01

Overview

Cytochrome P450 3A2 is an enzyme found primarily in rodent liver microsomes. It belongs to the cytochrome P450 superfamily and mediates the oxidative metabolism of many drugs, steroids, and toxins. The core structure contains a heme-iron center, which, upon substrate binding, facilitates oxygen transfer and the chemical transformation of substrates. This enzyme is critical for drug clearance, and its activity is modulated by various inhibitors and inducers, leading to clinically relevant pharmacokinetic interactions. In humans, the closely related CYP3A4 isozyme fulfills a similar function and is central to many adverse drug events and therapeutic outcomes

Other names
CYP3A2Cytochrome P450 3A2P450 3A2
02

Mechanism of action

Drug substrate oxidation (hydroxylation, demethylation, etc.) Enzyme inhibition (e.g., competitive, non-competitive inhibition by ketoconazole, erythromycin) Enzyme induction (e.g., by rifampicin, carbamazepine)

03

Biological functions

Drug metabolismSteroid metabolismOxidation of organic chemicalsDetoxification of xenobiotics
04

Disease associations

Altered drug responseDrug toxicityChanges in steroid levelsTherapeutic failure due to drug interactions
05

Safety considerations

Risk of drug-drug interactions leading to toxicityRisk of therapeutic failure from enzyme inductionIncreased risk of arrhythmia with some substrates (e.g., terfenadine, cisapride, due to metabolic inhibition)
06

Interacting drugs

Rifampicin

7 more in the full profile.

07

Biomarkers

Drug concentration monitoring (e.g., for ciclosporin, statins)Genetic polymorphism testing (for animal models, as relevant)

Beyond the preview

Go deeper on Cytochrome P450 3A2 (CYP3A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 3A2 (CYP3A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call